Member Exclusive

ASM Microbe 2018: Summit Therapeutics unveils second novel target for gonorrhea

At ASM Microbe (7–11 June, 2018), Summit Therapeutics announced the discovery of a second novel drug target to treat gonorrhea infection, highlighting the power of the Discuva platform.

Go to the profile of Jasmine Harris
Jun 11, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.